Pure Health Holding PJSC Valuation

Q: What is the Fair Price of PUREHEALTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

PUREHEALTH (AED3.91) is trading above our estimate of [[fair value]] (AED3.38)

Is PUREHEALTH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PUREHEALTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PUREHEALTH (AED3.91) is trading above our estimate of fair value (AED3.38)

Significantly Below Fair Value: PUREHEALTH is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PUREHEALTH?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for PUREHEALTH. This is calculated by dividing PUREHEALTH's market cap by their current preferred multiple.
What is PUREHEALTH's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	د.إ43.44b

PUREHEALTH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.7x
Enterprise Value/EBITDA	-405.8x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does PUREHEALTH's PE Ratio compare to its peers?

The above table shows the PE ratio for PUREHEALTH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18.8x
BURJEEL Burjeel Holdings	30.7x	32.3%	د.إ15.3b
GMPC Gulf Medical Projects Company (PJSC)	21x	n/a	د.إ1.3b
THC Tenet Healthcare	4.7x	-35.9%	US$12.5b
IHH IHH Healthcare Berhad	18.9x	-11.0%	RM55.7b
PUREHEALTH Pure Health Holding PJSC	35.1x	n/a	د.إ43.4b

Price-To-Earnings vs Peers: PUREHEALTH is expensive based on its Price-To-Earnings Ratio (35.1x) compared to the peer average (18.8x).

Price to Earnings Ratio vs Industry

How does PUREHEALTH's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	17.9%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	17.9%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: PUREHEALTH is expensive based on its Price-To-Earnings Ratio (35.1x) compared to the Asian Healthcare industry average (23.1x).

Price to Earnings Ratio vs Fair Ratio

What is PUREHEALTH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PUREHEALTH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	35.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PUREHEALTH's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.